A bidirectional autoimmune cluster between vitiligo and rheumatoid arthritis: a large-scale population-based study

Area of Science:

• Dermatology and Immunology
• Epidemiology
• Autoimmune Diseases

Background:

• A knowledge gap exists regarding the association between vitiligo and rheumatoid arthritis (RA).
• Large-scale cohort studies investigating this link are absent.
• Understanding this association is crucial for clinical practice.

Purpose of the Study:

• To investigate the bidirectional epidemiological association between vitiligo and rheumatoid arthritis (RA).
• To determine if vitiligo increases the risk of developing RA.
• To assess if RA increases the risk of developing vitiligo.

Main Methods:

• Population-based study using the Clalit Health Services (CHS) database (2002-2019).
• Employed both cohort and case-control study designs.
• Utilized multivariate Cox and logistic regressions to calculate adjusted hazard ratios (HR) and odds ratios (OR).

Main Results:

• Included 20,851 vitiligo patients and 102,475 controls.
• Vitiligo patients had a 1.44 times increased risk of new-onset RA (aHR=1.44, P=0.036).
• RA patients had a 1.67 times increased likelihood of developing vitiligo (aOR=1.67, P<0.001).
• Vitiligo patients with RA faced a 1.61 times higher risk of all-cause mortality (aHR=1.61, P=0.037).

Conclusions:

• The study confirms a bidirectional association between vitiligo and RA.
• Physicians should be aware of this association when treating vitiligo patients.
• This finding has implications for managing patients with either condition.